CLOVER CORPORATION LIMITED (CLV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CLV - CLOVER CORPORATION LIMITED

FNArena Sector : Health & Nutrition
Year End: July
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.32

25 May
2022

0.000

OPEN

$1.30

0.000

HIGH

$1.32

33,866

LOW

$1.26

TARGET
$1.63 23.5% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . MCP . API . BKL . EXL . SIG .
FNARENA'S MARKET CONSENSUS FORECASTS
CLV: 1
Title FY20
Actual		 FY21
Actual		 FY22
Forecast		 FY23
Forecast
EPS (cps) xxx 3.6 4.1 xxx
DPS (cps) xxx 1.0 1.5 xxx
EPS Growth xxx - 51.9% 13.6% xxx
DPS Growth xxx - 60.0% 50.0% xxx
PE Ratio xxx N/A 32.2 xxx
Dividend Yield xxx N/A 1.1% xxx
Div Pay Ratio(%) xxx 27.7% 36.6% xxx

Dividend yield today if purchased 3 years ago: 0.45%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.76

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/04 - ex-div 0.5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx3.6
DPS All xxxxxxxxxxxxxxx1.0
Sales/Revenue xxxxxxxxxxxxxxx60.5 M
Book Value Per Share xxxxxxxxxxxxxxx35.1
Net Operating Cash Flow xxxxxxxxxxxxxxx8.2 M
Net Profit Margin xxxxxxxxxxxxxxx9.92 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx10.35 %
Return on Invested Capital xxxxxxxxxxxxxxx8.50 %
Return on Assets xxxxxxxxxxxxxxx7.49 %
Return on Equity xxxxxxxxxxxxxxx10.35 %
Return on Total Capital xxxxxxxxxxxxxxx13.15 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

17/03/2022

1

Buy

$1.86

40.91%

Clover Corp's first half result was mixed, Ord Minnett suggests, with revenues stabilisng on a slight growth in sales but rising input costs from raw materials to transportation have killed off hopes of margin expansion.

The broker's infant formula industry outlook is nevertheless one of a turning tide, on improving pricing, inventory position and sales. The recent sell-off has brought Clover to an attactive entry point, the broker suggests. Buy retained.

Target falls to $1.86 from $1.90.

FORECAST
Ord Minnett forecasts a full year FY22 dividend of 1.50 cents and EPS of 5.20 cents.
Ord Minnett forecasts a full year FY23 dividend of 4.00 cents and EPS of 7.00 cents.
Access Stockbroker Research History >

CLV STOCK CHART

FNArena News on CLV

1
Weekly Ratings, Targets, Forecast Changes – 18-03-22

Mar 21 2022 - Weekly Reports
2
FNArena Corporate Results Monitor – 18-03-2022

Mar 18 2022 - Australia
3
Rudi’s View: Double Your Protection

Mar 17 2022 - Rudi's View
4
Rudi’s View: The Market Has A Carrot

Sep 30 2021 - Rudi's View
5
FNArena Corporate Results Monitor – 24-09-2021

Sep 24 2021 - Australia

Latest Health & Nutrition News

1
Sigma Healthcare: Brokers Wary

Mar 31 2022 - Australia
2
Health & Wellness Boom On The ASX

Apr 29 2021 - Weekly Reports
3
M&A Now On Sigma Healthcare’s Agenda

Mar 24 2021 - Australia
4
McPherson’s Expands Into Herbal Health

Nov 04 2020 - Small Caps
5
Nine Ignored Companies Now Worth A Look

Sep 23 2020 - FYI
6
Next Week At A Glance – 14-18 Sep 2020

Sep 11 2020 - Weekly Reports
7
Sigma Farewells API, Heralds New Contract

Dec 17 2019 - Australia
8
Blackmores: Hopes Pinned On Restructuring

Nov 01 2019 - Australia
9
Blackmores Peps Up Its Strategy For China

Apr 17 2019 - Australia
10
API/Sigma Merger Plan Rears, Again

Dec 17 2018 - Australia